North America Cough Syrup Market Forecast 2023-2032

The North America cough syrup market is evaluated to project a CAGR of 2.76% during the forecast period, 2023-2032. Cough syrups can be easily found in pharmacies, grocery stores, and online retailers across North America, ensuring convenient access for consumers when they require such products.

MARKET INSIGHTS

Canada and the United States are assessed for the North America cough syrup market growth analysis. The Canadian government has allocated $59 million to the Canadian Critical Drug Initiative, as part of its effort to bolster drug research, commercialization, and production in Alberta. The burgeoning pharmaceutical manufacturing sector in Canada is expected to stimulate the need for cough syrups within the nation. As Canada continues to expand its pharmaceutical industry and attract investments in research and development, there is an increasing emphasis on diversifying the range of pharmaceutical products, including cough syrups. This expanded domestic manufacturing capacity can result in several factors contributing to heightened demand for cough syrups.

With an emphasis on local production, potential economic incentives and reduced manufacturing and distribution costs may translate into more competitive pricing for domestically manufactured cough syrups. Lower pricing can enhance the accessibility of these products to a broader segment of the population, thereby driving up demand for the analyzed product.

COMPETITIVE INSIGHTS

Some of the leading companies in the market are: Acella Pharmaceuticals, Reckitt Benckiser Group PLC, AstraZeneca Plc, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 71424

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
- 2.4.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
- 2.4.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.5. MAJOR MARKET FINDINGS
- 2.5.1. PRODUCT DIVERSIFICATION IS ON THE RISE
- 2.5.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
- 2.5.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
- 3.1.2. RISING GERIATRIC POPULATION
- 3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
- 3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
- 3.2.2. STRINGENT REGULATORY PROTOCOLS
- 3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. INCREASING SELF-MEDICATION TRENDS
- 4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
- 4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
- 4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
- 4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4. VALUE CHAIN ANALYSIS

5. MARKET BY PRODUCT TYPE

5.1. COUGH SUPPRESSANTS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY AGE GROUP

6.1. ADULTS
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS

7. MARKET BY DISTRIBUTION CHANNEL

7.1. RETAIL PHARMACIES
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
- 7.3.1. MARKET FORECAST FIGURE
- 7.3.2. SEGMENT ANALYSIS

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. NORTH AMERICA COUGH SYRUP MARKET DRIVERS
- 8.1.3. NORTH AMERICA COUGH SYRUP MARKET CHALLENGES
- 8.1.4. NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED STATES
  - 8.1.6.1.1. UNITED STATES COUGH SYRUP MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. CANADA
  - 8.1.6.2.1. CANADA COUGH SYRUP MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBOTT LABORATORIES
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT LIST
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. ACELLA PHARMACEUTICALS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT LIST
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. ASTRAZENECA PLC
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT LIST
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CIPLA LTD
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. DABUR INDIA LTD
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT LIST
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. GLENMARK PHARMACEUTICALS LTD
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. GSK PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT LIST
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. HIMALAYA WELLNESS COMPANY
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. KENVUE
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. MERCK KGAA
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT LIST
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. NOVARTIS AG
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. PFIZER INC
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCT LIST
  - 9.2.12.3. STRENGTHS & CHALLENGES
- 9.2.13. PROCTER & GAMBLE
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. PRODUCT LIST
  - 9.2.13.3. STRENGTHS & CHALLENGES
- 9.2.14. RECKITT BENCKISER GROUP PLC
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCT LIST
  - 9.2.14.3. STRENGTHS & CHALLENGES
- 9.2.15. SANOFI
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCT LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

Product Code: 71424

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - COUGH SYRUP MARKET
TABLE 2: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA COUGH SYRUP MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA COUGH SYRUP MARKET, BY AGE GROUP, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA COUGH SYRUP MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
TABLE 11: KEY PLAYERS OPERATING IN NORTH AMERICA COUGH SYRUP MARKET
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: VALUE CHAIN ANALYSIS
FIGURE 5: NORTH AMERICA COUGH SYRUP MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2022
FIGURE 6: NORTH AMERICA COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS, 2023-2032 (IN $ MILLION)
FIGURE 7: NORTH AMERICA COUGH SYRUP MARKET, BY COMBINATION MEDICINES, 2023-2032 (IN $ MILLION)
FIGURE 8: NORTH AMERICA COUGH SYRUP MARKET, BY EXPECTORANTS, 2023-2032 (IN $ MILLION)
FIGURE 9: NORTH AMERICA COUGH SYRUP MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2022
FIGURE 10: NORTH AMERICA COUGH SYRUP MARKET, BY ADULTS, 2023-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA COUGH SYRUP MARKET, BY ADOLESCENTS, 2023-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA COUGH SYRUP MARKET, BY PEDIATRIC, 2023-2032 (IN $ MILLION)
FIGURE 13: NORTH AMERICA COUGH SYRUP MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022
FIGURE 14: NORTH AMERICA COUGH SYRUP MARKET, BY RETAIL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA COUGH SYRUP MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA COUGH SYRUP MARKET, BY E-PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 17: NORTH AMERICA COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 18: UNITED STATES COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)
FIGURE 19: CANADA COUGH SYRUP MARKET, 2023-2032 (IN $ MILLION)